Conagra Brands, Inc. (NYSE: CAG) Highlights Short List of Company Earnings For 10/2

Conagra Brands, Inc. (CAG) will report its earnings for the fiscal quarter ending August 31, 2024, on October 2, 2024. Analysts expect the company to post earnings per share (EPS) of $0.59, down from $0.65 in the same quarter last year. Conagra, a major player in the consumer packaged goods sector, has been facing significant … Read more

RPM International Inc. (NYSE: RPM) Earnings Preview

RPM International Inc. (RPM) is poised to release its earnings report for the fiscal quarter ending August 31, 2024, on October 2nd, 2024. Analysts expect the company to report earnings per share (EPS) of $1.75, continuing its trend of solid performance in the specialty chemicals sector. This forecast aligns with RPM’s historical ability to meet … Read more

Multiple Restaurant Chains Darden and Cracker Barrel Reporting Earnings Tomorrow

Darden Restaurants, Inc. (NYSE: DRI) is scheduled to release its earnings report for the first quarter of fiscal 2025 on September 19, 2024, before the market opens. Analysts are anticipating an earnings per share (EPS) of $1.83, representing a modest 2.8% increase from the same quarter last year, when EPS was $1.78.

Will Cracker Barrel Beat Earnings Tomorrow?

Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is set to release its earnings report for the fourth quarter of fiscal 2024 on September 19, 2024. Analysts project the company will post earnings per share (EPS) of approximately $1.10 to $1.17, reflecting a year-over-year decrease from the $1.25 reported in the same quarter last year. Revenue is expected to come in around $897 million, compared to $823 million in the previous quarter​.

Healthcare Company Guardian Pharmacy Services Issues 6.75 Million Shares Of Its Common Stock

The company intends to offer 6.75 million shares of Class A common stock at an expected price range of $14 to $16 per share. If priced at the midpoint of $15, the IPO would raise approximately $101.3 million and value the company at roughly $913 million.

Centessa Pharmaceuticals plc (NASDAQ: CNTA) Prices Follow On Offering

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biopharmaceutical company, has launched a follow-on public offering of $150 million in American Depositary Shares (ADSs), which represents one ordinary share per ADS. The underwriters for this offering, including prominent financial institutions such as Goldman Sachs, Evercore ISI, and Guggenheim Securities, also have the option to purchase up … Read more